Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Cappellini

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Haematologica|May 1, 1997
Silent thalassemiasM D Cappellini
Seminars in Hematology|April 23, 2005
Overcoming the challenge of patient compliance with iron chelation therapyM D Cappellini
Best Practice & Research. Clinical Haematology|March 2, 2005
Iron-chelating therapy with the new oral agent ICL670 (Exjade)M D Cappellini
Human Genetics|October 21, 2010
Gene symbol: HBD. Disease: Thalassaemia deltaChiara Refaldi, M D Cappellini
Haematologica|January 1, 1995
Thalassemia intermediaC Camaschella, M D Cappellini
Lancet (London, England)|January 8, 2008
Glucose-6-phosphate dehydrogenase deficiencyM D Cappellini, G Fiorelli
Acta Haematologica|November 13, 2009
Deferasirox (Exjade) for the treatment of iron overloadM D Cappellini, A Taher
Expert Opinion on Pharmacotherapy|August 20, 2008
Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overloadM D Cappellini, A Taher
British Journal of Haematology|May 1, 1983
Improved culture of BFU-E and CFC-GM by the use of an oil sealC G Potter, M D Cappellini
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathwayT Ikuta, S Ausenda, M D Cappellini
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Haematologica|May 1, 1997
Silent thalassemiasM D Cappellini
Seminars in Hematology|April 23, 2005
Overcoming the challenge of patient compliance with iron chelation therapyM D Cappellini
Best Practice & Research. Clinical Haematology|March 2, 2005
Iron-chelating therapy with the new oral agent ICL670 (Exjade)M D Cappellini
Human Genetics|October 21, 2010
Gene symbol: HBD. Disease: Thalassaemia deltaChiara Refaldi, M D Cappellini
Haematologica|January 1, 1995
Thalassemia intermediaC Camaschella, M D Cappellini
Lancet (London, England)|January 8, 2008
Glucose-6-phosphate dehydrogenase deficiencyM D Cappellini, G Fiorelli
Acta Haematologica|November 13, 2009
Deferasirox (Exjade) for the treatment of iron overloadM D Cappellini, A Taher
Expert Opinion on Pharmacotherapy|August 20, 2008
Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overloadM D Cappellini, A Taher
British Journal of Haematology|May 1, 1983
Improved culture of BFU-E and CFC-GM by the use of an oil sealC G Potter, M D Cappellini
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathwayT Ikuta, S Ausenda, M D Cappellini
Pageof 18